The NHS is set to trial an AI tool, Aire-DM, that predicts type 2 diabetes risk by analyzing ECG data. This innovative technology could identify at-risk patients up to 13 years before diagnosis, potentially transforming preventive healthcare. Trials will begin in 2025 at two London hospitals.